A site where you can find recommended contractors for non-clinical testing｜effical " Non-Clinical CROs and Agencies " Anapharm Bioanalytics (formerly: Anapharm Europe)

Anapharm Bioanalytics (formerly: Anapharm Europe)

Table of Contents

This article introduces Anapharm Bioanalytics, a company that possesses a team with extensive experience and a lab equipped with cutting-edge technology. We investigate and summarize the characteristics and strengths of the non-clinical studies they handle, as well as past case examples.

Non-clinical studies commissioned by Anapharm Bioanalytics

Technical expertise and a wealth of analytical methods

Anapharm Bioanalytics is equipped with advanced instruments, including LC-MS/MS.Provides a wide range of biological sample analyses from low molecular weight to high molecular weight.With over 30 years of experience, the company offers one-stop solutions from preclinical studies to Phase 3 and bioequivalence trials. They also have strengths in complex analyses, such as high-sensitivity assays below the picogram level.Technical expertise with numerous verified methodsWe offer

Strict quality assurance that meets international standards

At Anapharm Bioanalytics, where we place a very high importance on quality,Conduct studies in compliance with GLP (Good Laboratory Practice) and GCP (Good Clinical Practice).The company's Quality Assurance Unit is led by a director with extensive industry experience, ensuring the quality of research data through strict adherence to guidelines, continuous monitoring, process improvement, and staff training.

Emphasize transparent communication with customers.

Anapharm Bioanalytics champions a "customer-first" philosophy.We value transparent and effective communication.is a feature. Each project is assigned a dedicated Study Director. We provide prompt support and regular progress reports, meeting customer requirements throughout each project.

An example of a pathological model held by Anapharm Bioanalytics

Analyze biological samples

Anapharm Bioanalytics isAnalytical CRO specializing in biological sample analysisTherefore, we do not sell or provide specific animal disease models. We support non-clinical development by directly analyzing biological samples such as blood received from clients in our own laboratories.

Anapharm Bioanalytics Non-Clinical Study Case Examples

Over 20 years of proven experience since its establishment

Anapharm Bioanalytics isA long track record is a distinguishing feature.This can be said. Although specific compound names are not disclosed due to sponsor confidentiality, they have a wealth of experience and a proven track record of successfully conducting non-clinical TK (toxicokinetics) studies for novel small and large molecule pharmaceuticals and developing and validating molecular methods for biomarker measurement for over 20 years since their establishment.

Anapharm Bioanalytics Company Information

Address	Encuny 22, 2nd floor, 08038 Barcelona, Spain
Tel	+34 93 223 86 36
Website	https://www.anapharmbioanalytics.com/

3 Recommended Contract Research Organizations for Non-Clinical Studies
— by Target goal and Expertise

In drug discovery, the quality and efficiency of non-clinical studies have a direct impact on clinical success rates, development costs, and overall length of time required in R&D. In recent years, there has been more demand for clinically relevant data, globally accepted reliability, and accurate early-stage screening. Thus, it is more important than ever to select the right CRO (Contract Research Organization) for strategic approach.
In this article, we highlight three CROs with proven technical capabilities, expertise, and long standing track records. These are our TOP 3 choices based on their capabilities and the specific target goals of the researchers for their non-clinical studies.

Pharmacology (Efficacy) Studies
Replicate unknown pathological models and
Discovery to clinically oriented drug evaluation

SMC Laboratories, Inc.

Reference: SMC Laboratories, Inc. official website (https://www.smccro-lab.com/jp/)

SMC Laboratories, Inc. has established a disease models using patented mouse technologies. The company has established proprietary pathological models—particularly in liver disease and fibrosis—and continues to expand their approach across a wide range of models in cancer, inflammation, and metabolic diseases.
From exploratory research to clinically oriented efficacy evaluation, SMC offers customized study designs, dosing strategies, and evaluation analysis tailored to each project. Their collaborative approachallows researchers to discuss and refine study plans together with SMC’s expert scientists.
With flexible small-scale study options and strong technical support, SMC Laboratories, Inc. is an ideal partner for start-ups, biotech ventures, and academic institutions alike.

Consult study design and disease model development
with SMC Laboratories, Inc.

Consult SMC Laboratories
Call us

Safety Studies
Comprehensive Safety Evaluation for FIH Applications

Labcorp Holdings Inc.
(Labcorp Drug Development)

Reference: Labcorp Holdings Inc. official website (https://jp.labcorp.com/)

Labcorp Holdings Inc. provides a fully integrated GLP testing system aligned with international regulatory standards, including FDA, EMA, and PMDA requirements. All studies are conducted under ICH-compliant quality assurance, making it ready for data submission.
The company has extensive expertise in long-term toxicity studies such as Segment I–III reproductive and carcinogenicity studies, as well as 2-year chronic toxicity assessments.
Labcorp Holdings Inc.’s comprehensive approach enables sponsors to efficiently outsource the entire preclinical package from toxicology, toxicokinetic (TK), and safety pharmacology study design to execution. This accelerates a path to First-in-Human (FIH) trials. For most of the global drug developers, this all-in-one service structure minimizes cost, risk, and expedite the time before advancing to clinical phase.

Consult Labcorp Holdings Inc.
Discuss GLP/ICH-compliant study design for your FIH submission.

To labcorp.
Call us

Pharmacokinetic (PK/PD) Studies
High-Precision Bioanalysis for Clinically Predictive PK/PD Evaluation

PhoenixBio Co., Ltd.

Source: PhoenixBio Co., Ltd. Official Website (https://phoenixbio.co.jp/)

PhoenixBio Co., Ltd.offers pharmacokinetic and hepatic metabolism studies using their proprietary PXB-mouse®, a humanized-liver chimeric mouse model. This platform enables the acquisition of data with high clinical correlation in ADME, drug–to-drug interaction studies, bridging the gap between preclinical and clinical stages.
With advanced LC-MS/MS-based bioanalysis, PhoenixBio Co., Ltd. provides aseamless workflow from plasma concentration measurement and metabolite identification to quantitative validation.
The company offersan integrated evaluation analysiscovering pharmacokinetics, hepatotoxicity, and safety with flexibility to accommodate complex modalities such as oligonucleotide and middle-molecule therapeutics. For compounds where hepatic metabolism is a development bottleneck—or where quantitative, reproducible exposure data are critical—PhoenixBio Co., Ltd. delivers unmatched analytical precision and consistency.

Consult Phoenix Bio for PK/PD analysis with a clinical focus

Phoenix Bio.
Call us